Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raquel Lopez-Reig"'
Autor:
Andres Poveda, Ana Oaknin, Ignacio Romero, Angel Guerrero-Zotano, Lorena Fariñas-Madrid, Victor Rodriguez-Freixinos, Pedro Mallol, Raquel Lopez-Reig, Jose Antonio Lopez-Guerrero
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib has shown antitumor activity in patients with ovarian or breast cancer with or without BRCA1/2 mutations. Lurbinectedin is an ecteinascidin that generates DNA double-strand breaks. W
Externí odkaz:
https://doaj.org/article/d1515ed3222c482292aa0ffa3a73aad2
Autor:
Andres Poveda, Raquel Lopez-Reig, Ana Oaknin, Andres Redondo, Maria Jesus Rubio, Eva Guerra, Lorena Fariñas-Madrid, Alejandro Gallego, Victor Rodriguez-Freixinos, Antonio Fernandez-Serra, Oscar Juan, Ignacio Romero, Jose A. Lopez-Guerrero
Publikováno v:
Scientia
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Cancers; Volume 14; Issue 4; Pages: 915
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Cancers; Volume 14; Issue 4; Pages: 915
Endometrial cancer; Genomic instability; Olaparib Cáncer endometrial; Inestabilidad genómica; Olaparib Càncer d'endometri; Inestabilitat genòmica; Olaparib We hypothesized that the combination of olaparib and lurbinectedin maximizes DNA damage, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c01a2c809d9cf1cea6973e566a8c99
https://doi.org/10.3390/cancers14040915
https://doi.org/10.3390/cancers14040915
Publikováno v:
EJC Supplements, Vol 15, Iss , Pp 27-37 (2020)
Epithelial ovarian cancer (EOC) is a heterogeneous group of diseases with distinct biological and clinical behaviour. Despite the differences between them, the capability of tumour cells to continuously proliferate and avoid death is maintained among
Externí odkaz:
https://doaj.org/article/cde4487b39554eabbd67d95bd634420c